Literature DB >> 16087353

Effects of cognitive-behavioral therapy on brain activation in specific phobia.

Thomas Straube1, Madlen Glauer, Stefan Dilger, Hans-Joachim Mentzel, Wolfgang H R Miltner.   

Abstract

Little is known about the effects of successful psychotherapy on brain function in subjects with anxiety disorders. The present study aimed to identify changes in brain activation following cognitive-behavioral therapy (CBT) in subjects suffering from specific phobia. Using functional magnetic resonance imaging (fMRI), brain activation to spider videos was measured in 28 spider phobic and 14 healthy control subjects. Phobics were randomly assigned to a therapy-group (TG) and a waiting-list control group (WG). Both groups of phobics were scanned twice. Between scanning sessions, CBT was given to the TG. Before therapy, brain activation did not differ between both groups of phobics. As compared to control subjects, phobics showed greater responses to spider vs. control videos in the insula and anterior cingulate cortex (ACC). CBT strongly reduced phobic symptoms in the TG while the WG remained behaviorally unchanged. In the second scanning session, a significant reduction of hyperactivity in the insula and ACC was found in the TG compared to the WG. These results propose that increased activation in the insula and ACC is associated with specific phobia, whereas an attenuation of these brain responses correlates with successful therapeutic intervention.

Entities:  

Mesh:

Year:  2005        PMID: 16087353     DOI: 10.1016/j.neuroimage.2005.07.007

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  74 in total

Review 1.  Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety.

Authors:  Xia Chen; Joop van Gerven; Adam Cohen; Gabriel Jacobs
Journal:  Acta Pharmacol Sin       Date:  2018-12-05       Impact factor: 6.150

2.  Anatomical and functional overlap within the insula and anterior cingulate cortex during interoception and phobic symptom provocation.

Authors:  Xavier Caseras; Kevin Murphy; David Mataix-Cols; Marina López-Solà; Carles Soriano-Mas; Hector Ortriz; Jesus Pujol; Rafael Torrubia
Journal:  Hum Brain Mapp       Date:  2011-12-08       Impact factor: 5.038

3.  Exposure therapy triggers lasting reorganization of neural fear processing.

Authors:  Katherina K Hauner; Susan Mineka; Joel L Voss; Ken A Paller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-23       Impact factor: 11.205

Review 4.  Neuroimaging of Fear-Associated Learning.

Authors:  John A Greco; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2015-08-21       Impact factor: 7.853

5.  Network model of fear extinction and renewal functional pathways.

Authors:  A K Bruchey; J Shumake; F Gonzalez-Lima
Journal:  Neuroscience       Date:  2006-12-16       Impact factor: 3.590

6.  Enhanced metabolic capacity of the frontal cerebral cortex after Pavlovian conditioning.

Authors:  A K Bruchey; F Gonzalez-Lima
Journal:  Neuroscience       Date:  2007-12-04       Impact factor: 3.590

7.  Attention and amygdala activity: an fMRI study with spider pictures in spider phobia.

Authors:  Georg W Alpers; Antje B M Gerdes; Bernadette Lagarie; Katharina Tabbert; Dieter Vaitl; Rudolf Stark
Journal:  J Neural Transm (Vienna)       Date:  2008-08-26       Impact factor: 3.575

8.  Neural substrates of defensive reactivity in two subtypes of specific phobia.

Authors:  Ulrike Lueken; Kevin Hilbert; Veronika Stolyar; Nina I Maslowski; Katja Beesdo-Baum; Hans-Ulrich Wittchen
Journal:  Soc Cogn Affect Neurosci       Date:  2013-10-29       Impact factor: 3.436

9.  Neurophysiological markers that predict and track treatment outcomes in childhood anxiety.

Authors:  Kathryn M Hum; Katharina Manassis; Marc D Lewis
Journal:  J Abnorm Child Psychol       Date:  2013-11

Review 10.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.